William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 13,000 shares at $39.60 ($515K) on 2011-07-07, disclosed to the SEC on 2011-07-11.
Scheduled sale ($515k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |